Lux Capital is a venture capital firm established in 2000 and headquartered in New York, New York. The firm specializes in investments in early-stage and growth companies, focusing on sectors such as biochemistry, material science, electronics, infrastructure, and aerospace. With over $5 billion in assets under management, Lux Capital takes an active role in supporting entrepreneurs, aiming to build successful businesses in high-growth industries. The investment team has a track record of founding more than 20 companies, employing strategies that enhance connectivity, insight, and competitive leadership for its portfolio companies. As a Registered Investment Adviser, Lux Capital is committed to fostering innovation at the intersection of technology and the sciences.
Ramp is a company that specializes in providing modern solutions for financial operations and enterprise content delivery. Its financial platform includes tools for corporate card management, expense tracking, bill payments, and seamless accounting integrations, aimed at helping organizations optimize their financial tasks and reduce costs. Additionally, Ramp offers advanced video management and delivery software, enabling companies to enhance video content discovery, user engagement, and secure delivery. Its products, such as VideoVerge and AltitudeCDN, leverage innovative technologies like speech-to-text and natural language processing to create rich metadata for video assets, allowing them to be effectively integrated into popular content management systems. Ramp serves a diverse clientele, including prominent media companies and organizations across various industries such as healthcare, finance, and technology. Founded in 1948 and based in Boston, Massachusetts, Ramp operates as a subsidiary of Raytheon BBN Technologies Corporation.
Maven Clinic
Series F in 2024
Maven Clinic operates an on-demand digital care clinic focused on supporting mothers and families through conception, pregnancy, and postpartum phases. The clinic provides access to video appointments and private messaging with a network of women's and family health practitioners, along with a comprehensive family benefits platform. Its services encompass various tracks, including IVF, egg freezing, pregnancy, postpartum, partner support, adoption, surrogacy, and loss, in addition to career coaching and customized training for human resources professionals. Founded in 2014 and headquartered in New York City, Maven Clinic caters to individuals, employers, and healthcare professionals, aiming to enhance family health and well-being through accessible digital care.
Egenesis
Series D in 2024
Egenesis Inc. is a biotechnology company focused on gene editing and genome engineering to create human transplantable organs, tissues, and cells. Established in 2015 and headquartered in Cambridge, Massachusetts, with an additional office in New York City, Egenesis aims to address the global organ shortage by developing solid organs and therapeutic cell transplantation solutions for various diseases. The company utilizes a gene editing platform that incorporates techniques such as single-cell cloning and somatic cell nuclear transfer, which are essential for creating human-compatible organ tissues and cells. Egenesis is particularly engaged in advancing programs related to kidney and islet cell transplantation, striving to provide alternative treatment options for patients with life-threatening conditions.
Ramp
Series D in 2024
Ramp is a company that specializes in providing modern solutions for financial operations and enterprise content delivery. Its financial platform includes tools for corporate card management, expense tracking, bill payments, and seamless accounting integrations, aimed at helping organizations optimize their financial tasks and reduce costs. Additionally, Ramp offers advanced video management and delivery software, enabling companies to enhance video content discovery, user engagement, and secure delivery. Its products, such as VideoVerge and AltitudeCDN, leverage innovative technologies like speech-to-text and natural language processing to create rich metadata for video assets, allowing them to be effectively integrated into popular content management systems. Ramp serves a diverse clientele, including prominent media companies and organizations across various industries such as healthcare, finance, and technology. Founded in 1948 and based in Boston, Massachusetts, Ramp operates as a subsidiary of Raytheon BBN Technologies Corporation.
Ramp
Series D in 2023
Ramp is a company that specializes in providing modern solutions for financial operations and enterprise content delivery. Its financial platform includes tools for corporate card management, expense tracking, bill payments, and seamless accounting integrations, aimed at helping organizations optimize their financial tasks and reduce costs. Additionally, Ramp offers advanced video management and delivery software, enabling companies to enhance video content discovery, user engagement, and secure delivery. Its products, such as VideoVerge and AltitudeCDN, leverage innovative technologies like speech-to-text and natural language processing to create rich metadata for video assets, allowing them to be effectively integrated into popular content management systems. Ramp serves a diverse clientele, including prominent media companies and organizations across various industries such as healthcare, finance, and technology. Founded in 1948 and based in Boston, Massachusetts, Ramp operates as a subsidiary of Raytheon BBN Technologies Corporation.
Chronosphere
Venture Round in 2023
Chronosphere, Inc. is a technology company that specializes in developing an open-source metrics data platform known as M3. Founded in 2019 and headquartered in New York, the company has additional offices in Seattle, Vilnius, and Warsaw. Chronosphere's platform provides comprehensive monitoring solutions for infrastructure, applications, and business metrics, enabling organizations to manage the complexities of cloud-native environments. By offering tools that help DevOps teams quickly identify and resolve issues across various layers of the technology stack, Chronosphere enhances operational reliability and supports data-driven decision-making. The platform is utilized by prominent brands to improve developer productivity, control costs, and enhance customer satisfaction.
Maven Clinic
Series E in 2022
Maven Clinic operates an on-demand digital care clinic focused on supporting mothers and families through conception, pregnancy, and postpartum phases. The clinic provides access to video appointments and private messaging with a network of women's and family health practitioners, along with a comprehensive family benefits platform. Its services encompass various tracks, including IVF, egg freezing, pregnancy, postpartum, partner support, adoption, surrogacy, and loss, in addition to career coaching and customized training for human resources professionals. Founded in 2014 and headquartered in New York City, Maven Clinic caters to individuals, employers, and healthcare professionals, aiming to enhance family health and well-being through accessible digital care.
Hugging Face
Series C in 2022
Hugging Face, Inc. is an open-source platform provider specializing in machine learning technologies, founded in 2016 and headquartered in New York City. The company focuses on democratizing machine learning by facilitating collaboration on models, datasets, and applications within a community-driven environment. Hugging Face offers tools and services that allow users to create, discover, and collaborate on machine learning projects. In addition to its community platform, the company provides paid computing and enterprise solutions aimed at accelerating development processes. Through its commitment to open-source practices, Hugging Face supports users in advancing the field of machine learning.
Pawp
Venture Round in 2022
Pawp, Inc. is a digital health clinic and telehealth platform focused on pet care, connecting pet owners with licensed veterinary professionals. Founded in 2020 and based in New York, the platform offers users unlimited 24/7 access to veterinarians, allowing for timely consultations that can often replace unnecessary in-person visits. Additionally, Pawp provides a yearly pet emergency fund of $3,000, serving as a financial safety net for unexpected veterinary expenses. By facilitating these services, Pawp aims to empower pet owners to make informed health decisions for their pets while managing costs effectively.
Kallyope
Series D in 2022
Kallyope Inc. is a biotechnology company based in New York City that focuses on the gut-brain axis to develop innovative therapeutics and consumer products aimed at enhancing human health. Founded in 2014, Kallyope employs a multidisciplinary approach, integrating technologies such as sequencing, computational biology, neural imaging, and human genetics to deepen the understanding of gut-brain biology. This comprehensive understanding enables the company to create effective and well-tolerated oral medications targeting various health issues, including diabetes, obesity, gut disorders, inflammatory diseases, migraines, and allergies. With a team of experienced scientists and a strong foundation in drug discovery, Kallyope aims to address significant unmet medical needs through its research and development efforts.
Parallel Markets
Series A in 2022
Parallel Markets Inc. is a New York-based company founded in 2018 that specializes in identity verification and accreditation for financial platforms. The company operates an online platform that simplifies the onboarding and verification process for both investors and investment platforms. It enables investors to authenticate and share their credentials across various platforms with a single click, streamlining the way individuals and entities assert their qualifications. Parallel Markets provides a comprehensive suite of identity products, facilitating efficient investor verification and allowing for easier engagement in the investment process. By focusing on user-friendly solutions, the company aims to enhance the overall experience of onboarding for its partners and their clients.
Anchorage Digital
Series D in 2021
Anchorage Digital is a regulated cryptocurrency platform that offers integrated financial services and infrastructure solutions tailored for institutions. Established in 2017 and headquartered in San Francisco, California, the company operates as the only federally chartered crypto bank in the United States, with an additional office in Singapore that maintains similar security and service standards. Anchorage Digital specializes in secure custody, regulatory compliance, and a variety of cryptocurrency-related services, including trading, staking, and governance. The platform emphasizes modern security engineering to ensure the safety of digital assets while facilitating streamlined participation in blockchain technology for businesses and institutions. With a valuation exceeding $3 billion, Anchorage Digital has attracted investments from prominent firms such as Andreessen Horowitz, Goldman Sachs, and Visa, among others. The company also supports a remote-friendly work environment, with additional offices located in New York, Porto, and Sioux Falls.
H1.co
Series C in 2021
H1 is a healthcare data analytics company based in New York, founded in 2017. It offers a global platform that connects life sciences companies, hospitals, academic medical centers, and health systems with healthcare providers, clinical research opportunities, and industry experts. The platform focuses on delivering real-time data to support decision-making throughout the therapeutic development process, from fundraising to product launch. By providing access to comprehensive information on healthcare professionals and institutions, H1 facilitates connections within the healthcare ecosystem, enabling organizations and professionals to gain live insights that accelerate the discovery and development of therapies aimed at combating diseases.
Clarifai
Series C in 2021
Clarifai, Inc. is a prominent provider of advanced artificial intelligence solutions specializing in image recognition, natural language processing, and audio recognition. Founded in 2013 by Matt Zeiler, Ph.D., the company develops a deep learning platform that enables organizations to convert unstructured data—such as images, videos, text, and audio—into structured data efficiently and accurately. Clarifai's image recognition technology is capable of detecting near-duplicates, categorizing objects, and tagging images, while also allowing users to search for similar images within extensive uncategorized collections through a combination of semantic and visual similarity. Additionally, the company offers a labeling tool called Labeler, which aids in dataset labeling, AI training, and model auto-scaling in production environments. Headquartered in New York, with an office in Tallinn, Estonia, Clarifai employs a distributed team across various countries, including the United States, Canada, Argentina, and India.
Chronosphere
Series C in 2021
Chronosphere, Inc. is a technology company that specializes in developing an open-source metrics data platform known as M3. Founded in 2019 and headquartered in New York, the company has additional offices in Seattle, Vilnius, and Warsaw. Chronosphere's platform provides comprehensive monitoring solutions for infrastructure, applications, and business metrics, enabling organizations to manage the complexities of cloud-native environments. By offering tools that help DevOps teams quickly identify and resolve issues across various layers of the technology stack, Chronosphere enhances operational reliability and supports data-driven decision-making. The platform is utilized by prominent brands to improve developer productivity, control costs, and enhance customer satisfaction.
Kingdom Supercultures
Series A in 2021
Kingdom Supercultures specializes in the development and production of microbial cultures that assist food manufacturers in creating innovative food products. Founded in 2019 and based in Brooklyn, New York, the company offers Koji, a traditional Japanese ingredient used in various fermented foods and beverages. Their technology utilizes an extensive biobank of Generally Recognized As Safe (GRAS) microbial strains and employs automated systems to characterize and assemble these strains into new combinations. This enables the production of plant-based foods that replicate dairy flavors, low-alcohol beverages with rich taste, and effective natural preservatives. Kingdom Supercultures collaborates with clients across multiple sectors, including food, beverage, personal care, and beauty, focusing on enhancing the health and sustainability of food offerings.
Shapeways
Post in 2021
Shapeways, Inc. is a 3D printing marketplace and community that allows users to create, buy, and sell customized products across various categories, including art, fashion, home goods, gadgets, games, jewelry, DIY projects, miniatures, and gifts. Founded in 2008 and headquartered in New York, with additional offices in Eindhoven, Netherlands, and Seattle, Washington, Shapeways utilizes on-demand printing to ensure that each order is tailored to individual specifications. The platform not only facilitates the transformation of digital designs into physical products but also fosters a community where members can share ideas and access advanced 3D printing technology. By democratizing the creation process, Shapeways empowers users to launch their own businesses and sell products globally.
Pager
Series C in 2021
Pager, Inc. operates an on-demand service platform that connects patients with healthcare services in various settings, including their homes, offices, and hotels. The company offers a mobile application that addresses urgent care needs such as infections, fevers, and allergies, while also providing services like nurse chat, teleconsultations, screening, vaccinations, and prescription delivery. Pager aims to improve healthcare access and decision-making by employing a flexible platform that serves health plans and systems, enhancing consumer experience through information, guidance, and coordination. By integrating clinical and service teams with advanced technology, Pager facilitates triage, telemedicine, appointment scheduling, and health advocacy, fostering a comprehensive care experience. The company, incorporated in 2013 and based in New York, supports over 15 million covered lives in the United States and Latin America.
Statespace
Series C in 2021
StateSpace provides performance analytics and a suite of tools for casual gamers and esports athletes to maximize their potential. It uses cognitive science and artificial intelligence to revolutionize the way humans improve. Leveraging expertise as neuroscientists, data scientists, video game developers, and computer visionaries, the products bring much needed standardized performance analytics to train.It was founded in 2017 and is headquartered in New York, New York.
Ramp
Series C in 2021
Ramp is a company that specializes in providing modern solutions for financial operations and enterprise content delivery. Its financial platform includes tools for corporate card management, expense tracking, bill payments, and seamless accounting integrations, aimed at helping organizations optimize their financial tasks and reduce costs. Additionally, Ramp offers advanced video management and delivery software, enabling companies to enhance video content discovery, user engagement, and secure delivery. Its products, such as VideoVerge and AltitudeCDN, leverage innovative technologies like speech-to-text and natural language processing to create rich metadata for video assets, allowing them to be effectively integrated into popular content management systems. Ramp serves a diverse clientele, including prominent media companies and organizations across various industries such as healthcare, finance, and technology. Founded in 1948 and based in Boston, Massachusetts, Ramp operates as a subsidiary of Raytheon BBN Technologies Corporation.
Maven Clinic
Series D in 2021
Maven Clinic operates an on-demand digital care clinic focused on supporting mothers and families through conception, pregnancy, and postpartum phases. The clinic provides access to video appointments and private messaging with a network of women's and family health practitioners, along with a comprehensive family benefits platform. Its services encompass various tracks, including IVF, egg freezing, pregnancy, postpartum, partner support, adoption, surrogacy, and loss, in addition to career coaching and customized training for human resources professionals. Founded in 2014 and headquartered in New York City, Maven Clinic caters to individuals, employers, and healthcare professionals, aiming to enhance family health and well-being through accessible digital care.
Genvid Technologies
Series C in 2021
Genvid Technologies develops software tools for eSports interactive streaming. It was created by a team of veterans who pioneered innovations in server-side gaming. Genvid's technologies are built for game developers and broadcasting companies looking for tools tailored with games in mind. It is the first developer-grade broadcast technology, integrated with game engines. Founded in 2016, Genvid Technologies is based in New York City.
Latch
Post in 2021
Latch is a company that enhances the living and working experience in buildings through a comprehensive operating system that includes software, devices, and services. Specializing in keyless entry security systems, Latch enables users to manage access to apartment buildings via a smartphone, facilitating seamless interactions for residents, guests, couriers, and service providers. Its platform, LatchOS, is implemented across North America, serving a diverse range of properties from affordable housing in Baltimore to historic buildings in Manhattan and luxury towers in the Midwest. Latch collaborates with a variety of real estate developers, catering to both large international firms and local property owners, to create better living environments.
Dyno Therapeutics
Series A in 2021
Dyno Therapeutics Inc. is a biotechnology company based in Cambridge, Massachusetts, focused on developing innovative adeno-associated virus (AAV) vectors for gene therapy applications. Founded in 2018, the company employs an artificial intelligence-powered platform that integrates next-generation DNA synthesis, high-throughput sequencing, and machine learning. This advanced approach allows Dyno Therapeutics to design and optimize cell-targeting capsids, which are crucial for the effective and safe delivery of gene therapies. By leveraging its technology, the company aims to provide medical researchers with novel AAV vectors that enhance the efficacy of in vivo therapeutic solutions.
Pawp
Series A in 2021
Pawp, Inc. is a digital health clinic and telehealth platform focused on pet care, connecting pet owners with licensed veterinary professionals. Founded in 2020 and based in New York, the platform offers users unlimited 24/7 access to veterinarians, allowing for timely consultations that can often replace unnecessary in-person visits. Additionally, Pawp provides a yearly pet emergency fund of $3,000, serving as a financial safety net for unexpected veterinary expenses. By facilitating these services, Pawp aims to empower pet owners to make informed health decisions for their pets while managing costs effectively.
Hugging Face
Series B in 2021
Hugging Face, Inc. is an open-source platform provider specializing in machine learning technologies, founded in 2016 and headquartered in New York City. The company focuses on democratizing machine learning by facilitating collaboration on models, datasets, and applications within a community-driven environment. Hugging Face offers tools and services that allow users to create, discover, and collaborate on machine learning projects. In addition to its community platform, the company provides paid computing and enterprise solutions aimed at accelerating development processes. Through its commitment to open-source practices, Hugging Face supports users in advancing the field of machine learning.
Anchorage Digital
Series C in 2021
Anchorage Digital is a regulated cryptocurrency platform that offers integrated financial services and infrastructure solutions tailored for institutions. Established in 2017 and headquartered in San Francisco, California, the company operates as the only federally chartered crypto bank in the United States, with an additional office in Singapore that maintains similar security and service standards. Anchorage Digital specializes in secure custody, regulatory compliance, and a variety of cryptocurrency-related services, including trading, staking, and governance. The platform emphasizes modern security engineering to ensure the safety of digital assets while facilitating streamlined participation in blockchain technology for businesses and institutions. With a valuation exceeding $3 billion, Anchorage Digital has attracted investments from prominent firms such as Andreessen Horowitz, Goldman Sachs, and Visa, among others. The company also supports a remote-friendly work environment, with additional offices located in New York, Porto, and Sioux Falls.
Chronosphere
Series B in 2021
Chronosphere, Inc. is a technology company that specializes in developing an open-source metrics data platform known as M3. Founded in 2019 and headquartered in New York, the company has additional offices in Seattle, Vilnius, and Warsaw. Chronosphere's platform provides comprehensive monitoring solutions for infrastructure, applications, and business metrics, enabling organizations to manage the complexities of cloud-native environments. By offering tools that help DevOps teams quickly identify and resolve issues across various layers of the technology stack, Chronosphere enhances operational reliability and supports data-driven decision-making. The platform is utilized by prominent brands to improve developer productivity, control costs, and enhance customer satisfaction.
H1.co
Series B in 2020
H1 is a healthcare data analytics company based in New York, founded in 2017. It offers a global platform that connects life sciences companies, hospitals, academic medical centers, and health systems with healthcare providers, clinical research opportunities, and industry experts. The platform focuses on delivering real-time data to support decision-making throughout the therapeutic development process, from fundraising to product launch. By providing access to comprehensive information on healthcare professionals and institutions, H1 facilitates connections within the healthcare ecosystem, enabling organizations and professionals to gain live insights that accelerate the discovery and development of therapies aimed at combating diseases.
Workit Health
Series B in 2020
Workit Health, Inc. is a provider of online therapeutic content and professional counseling services focused on substance use recovery. Established in 2014 and based in Ann Arbor, Michigan, the company operates the Workit platform, which offers clinically proven telemedicine treatment for substance use disorder, including online therapy, medication-assisted treatment, psychiatric support, and primary care. Workit Health's services are designed to help individuals achieve long-term recovery from drugs and alcohol while minimizing disruption to their daily lives. The platform facilitates access to on-demand, in-person, and virtual medical and psychosocial support, catering to a wide range of clients including employers, educational institutions, healthcare facilities, and recovery communities. Additionally, Workit Health provides accredited opioid addiction treatment featuring buprenorphine, enhancing its commitment to harm reduction in addiction care. The company has locations in California, New Jersey, Alaska, and Washington.
Thrive Earlier Detection
Series B in 2020
Thrive Earlier Detection Corp. is a healthcare company that specializes in developing advanced blood testing technologies for early cancer detection. Its flagship product, CancerSEEK, is a liquid biopsy test that analyzes genomic mutations in tumor DNA and protein markers in plasma, allowing for the identification of various cancers at their nascent stages, often before symptoms manifest. Founded in 2018 and headquartered in Cambridge, Massachusetts, with an additional office in Baltimore, Maryland, Thrive aims to integrate cancer screening into standard medical practice. The company leverages real-world data and machine learning to enhance the accuracy of cancer detection, facilitate follow-up testing, and streamline the transition to oncological care. Thrive operates as a subsidiary of Exact Sciences Corporation and has received investments from notable firms including Third Rock Ventures and Section 32.
Statespace
Series A in 2020
StateSpace provides performance analytics and a suite of tools for casual gamers and esports athletes to maximize their potential. It uses cognitive science and artificial intelligence to revolutionize the way humans improve. Leveraging expertise as neuroscientists, data scientists, video game developers, and computer visionaries, the products bring much needed standardized performance analytics to train.It was founded in 2017 and is headquartered in New York, New York.
Looking Glass
Series A in 2020
Looking Glass Factory is a company focused on developing holographic technology, primarily through its flagship product, the Looking Glass, which is the first desktop holographic display designed for 3D creators. Founded in 2015 and based in Brooklyn, New York, with a subsidiary in Hong Kong, the company aims to make 3D creation accessible without the need for virtual reality or augmented reality headsets. Looking Glass Factory also offers a web-based holographic sharing platform that utilizes light field rendering software, allowing artists, designers, developers, filmmakers, and photographers to engage with 3D content in an innovative manner.
Pager
Series B in 2020
Pager, Inc. operates an on-demand service platform that connects patients with healthcare services in various settings, including their homes, offices, and hotels. The company offers a mobile application that addresses urgent care needs such as infections, fevers, and allergies, while also providing services like nurse chat, teleconsultations, screening, vaccinations, and prescription delivery. Pager aims to improve healthcare access and decision-making by employing a flexible platform that serves health plans and systems, enhancing consumer experience through information, guidance, and coordination. By integrating clinical and service teams with advanced technology, Pager facilitates triage, telemedicine, appointment scheduling, and health advocacy, fostering a comprehensive care experience. The company, incorporated in 2013 and based in New York, supports over 15 million covered lives in the United States and Latin America.
Kallyope
Series C in 2020
Kallyope Inc. is a biotechnology company based in New York City that focuses on the gut-brain axis to develop innovative therapeutics and consumer products aimed at enhancing human health. Founded in 2014, Kallyope employs a multidisciplinary approach, integrating technologies such as sequencing, computational biology, neural imaging, and human genetics to deepen the understanding of gut-brain biology. This comprehensive understanding enables the company to create effective and well-tolerated oral medications targeting various health issues, including diabetes, obesity, gut disorders, inflammatory diseases, migraines, and allergies. With a team of experienced scientists and a strong foundation in drug discovery, Kallyope aims to address significant unmet medical needs through its research and development efforts.
Vesta Healthcare
Series A in 2020
Vesta Healthcare is a technology and clinical services organization that focuses on enhancing the connection between caregivers and the broader care team. The company provides 24/7 telehealth support for caregivers and care recipients, particularly targeting high-need, frail senior populations. By partnering with home care agencies, health plans, and healthcare providers, Vesta Healthcare develops value-based population health programs that prioritize clinical quality, improved health outcomes, and personalized engagement. Originally established as Hometeam Technologies, Inc. in 2008, the company rebranded to Vesta Healthcare in January 2020 and is headquartered in New York, New York.
Evolv Technology
Series C in 2020
Evolv Technology specializes in AI-based touchless security screening systems that prioritize safety while enhancing the visitor experience. The company's Mosaiq Platform integrates real-time video surveillance with advanced detection capabilities for firearms and explosives, facial recognition, and security analytics, all designed to minimize false alarms. Headquartered in Waltham, Massachusetts, Evolv is led by professionals with extensive backgrounds in security, including experience with the TSA, FBI, CIA, Secret Service, and Homeland Security. The firm offers its products through direct sales and a multi-year security-as-a-service subscription model, which not only provides ongoing value to clients but also fosters predictable revenue streams and opportunities for expansion. Evolv Technology aims to protect both public and private sectors by securing soft targets and vital assets.
Adimab
Venture Round in 2020
Adimab LLC is a biotechnology company based in Lebanon, New Hampshire, focused on the discovery, development, and optimization of human monoclonal and bispecific antibodies. Founded in 2007, Adimab utilizes an integrated antibody discovery platform that accelerates the process from antigen identification to the production of purified, full-length human IgGs. The company specializes in various antibody formats, including IgG, scFv, and CD3-based bispecific antibodies, which are designed to meet stringent criteria for affinity, epitope coverage, and cross-reactivity. Adimab's innovative approach enables its partners to enhance their biologics pipelines and effectively address therapeutic needs in areas such as cancer, autoimmune, and infectious diseases through a range of technology access arrangements.
Hugging Face
Series A in 2019
Hugging Face, Inc. is an open-source platform provider specializing in machine learning technologies, founded in 2016 and headquartered in New York City. The company focuses on democratizing machine learning by facilitating collaboration on models, datasets, and applications within a community-driven environment. Hugging Face offers tools and services that allow users to create, discover, and collaborate on machine learning projects. In addition to its community platform, the company provides paid computing and enterprise solutions aimed at accelerating development processes. Through its commitment to open-source practices, Hugging Face supports users in advancing the field of machine learning.
Onaroll
Pre Seed Round in 2019
Onaroll is an employee rewards app that incentivizes productivity and longevity. It was founded by Pete Ginsberg in 2019 and is headquartered in New York City.
Chronosphere
Series A in 2019
Chronosphere, Inc. is a technology company that specializes in developing an open-source metrics data platform known as M3. Founded in 2019 and headquartered in New York, the company has additional offices in Seattle, Vilnius, and Warsaw. Chronosphere's platform provides comprehensive monitoring solutions for infrastructure, applications, and business metrics, enabling organizations to manage the complexities of cloud-native environments. By offering tools that help DevOps teams quickly identify and resolve issues across various layers of the technology stack, Chronosphere enhances operational reliability and supports data-driven decision-making. The platform is utilized by prominent brands to improve developer productivity, control costs, and enhance customer satisfaction.
Evolv Technology
Series C in 2019
Evolv Technology specializes in AI-based touchless security screening systems that prioritize safety while enhancing the visitor experience. The company's Mosaiq Platform integrates real-time video surveillance with advanced detection capabilities for firearms and explosives, facial recognition, and security analytics, all designed to minimize false alarms. Headquartered in Waltham, Massachusetts, Evolv is led by professionals with extensive backgrounds in security, including experience with the TSA, FBI, CIA, Secret Service, and Homeland Security. The firm offers its products through direct sales and a multi-year security-as-a-service subscription model, which not only provides ongoing value to clients but also fosters predictable revenue streams and opportunities for expansion. Evolv Technology aims to protect both public and private sectors by securing soft targets and vital assets.
Statespace
Seed Round in 2019
StateSpace provides performance analytics and a suite of tools for casual gamers and esports athletes to maximize their potential. It uses cognitive science and artificial intelligence to revolutionize the way humans improve. Leveraging expertise as neuroscientists, data scientists, video game developers, and computer visionaries, the products bring much needed standardized performance analytics to train.It was founded in 2017 and is headquartered in New York, New York.
CTRL-Labs
Venture Round in 2019
CTRL-Labs Corporation, founded in 2015 and based in New York City, specializes in developing non-invasive neural interface technology aimed at enhancing the interaction between humans and machines. The company's flagship product, the CTRL-kit, is a wireless wristband equipped with sensors that captures neural signals, allowing users to control digital devices through simple electronic pulses. This innovative platform is designed to support various applications in virtual reality, augmented reality, robotics, productivity, and clinical research. By providing developers with a software development kit (SDK) and application programming interface (API), CTRL-Labs enables the integration of neural control into their applications. The company's long-term vision focuses on fostering mass consumer adoption of neural interfaces, establishing a new standard for human-machine collaboration that transforms how users engage with technology.
Zipdrug
Venture Round in 2019
Zipdrug, Inc. is a New York-based company that develops a mobile application designed to streamline the process of obtaining prescribed medications. Founded in 2015, the application connects users with a network of low-cost pharmacies that deliver prescriptions directly to patients' homes, eliminating the need to wait at traditional pharmacies. By focusing on Medicare and Medicaid patients, Zipdrug aims to enhance medication adherence while providing a personalized pharmacy experience at competitive prices. As of July 2020, Zipdrug operates as a subsidiary of IngenioRx, Inc.
Kallyope
Series B in 2018
Kallyope Inc. is a biotechnology company based in New York City that focuses on the gut-brain axis to develop innovative therapeutics and consumer products aimed at enhancing human health. Founded in 2014, Kallyope employs a multidisciplinary approach, integrating technologies such as sequencing, computational biology, neural imaging, and human genetics to deepen the understanding of gut-brain biology. This comprehensive understanding enables the company to create effective and well-tolerated oral medications targeting various health issues, including diabetes, obesity, gut disorders, inflammatory diseases, migraines, and allergies. With a team of experienced scientists and a strong foundation in drug discovery, Kallyope aims to address significant unmet medical needs through its research and development efforts.
Latch
Series B in 2018
Latch is a company that enhances the living and working experience in buildings through a comprehensive operating system that includes software, devices, and services. Specializing in keyless entry security systems, Latch enables users to manage access to apartment buildings via a smartphone, facilitating seamless interactions for residents, guests, couriers, and service providers. Its platform, LatchOS, is implemented across North America, serving a diverse range of properties from affordable housing in Baltimore to historic buildings in Manhattan and luxury towers in the Midwest. Latch collaborates with a variety of real estate developers, catering to both large international firms and local property owners, to create better living environments.
CTRL-Labs
Series B in 2018
CTRL-Labs Corporation, founded in 2015 and based in New York City, specializes in developing non-invasive neural interface technology aimed at enhancing the interaction between humans and machines. The company's flagship product, the CTRL-kit, is a wireless wristband equipped with sensors that captures neural signals, allowing users to control digital devices through simple electronic pulses. This innovative platform is designed to support various applications in virtual reality, augmented reality, robotics, productivity, and clinical research. By providing developers with a software development kit (SDK) and application programming interface (API), CTRL-Labs enables the integration of neural control into their applications. The company's long-term vision focuses on fostering mass consumer adoption of neural interfaces, establishing a new standard for human-machine collaboration that transforms how users engage with technology.
Shapeways
Series E in 2018
Shapeways, Inc. is a 3D printing marketplace and community that allows users to create, buy, and sell customized products across various categories, including art, fashion, home goods, gadgets, games, jewelry, DIY projects, miniatures, and gifts. Founded in 2008 and headquartered in New York, with additional offices in Eindhoven, Netherlands, and Seattle, Washington, Shapeways utilizes on-demand printing to ensure that each order is tailored to individual specifications. The platform not only facilitates the transformation of digital designs into physical products but also fosters a community where members can share ideas and access advanced 3D printing technology. By democratizing the creation process, Shapeways empowers users to launch their own businesses and sell products globally.
Kyruus
Corporate Round in 2018
Kyruus, Inc. is a Boston-based company that develops web-based software solutions aimed at optimizing physician networks for hospitals, health systems, and life science companies. Founded in 2010, Kyruus offers a suite of analytically driven products designed to enhance provider search and scheduling, ensuring that patients are matched with the most suitable healthcare providers. Key offerings include Kyruus Passport, which allows physicians to track their activity and productivity, and Kyruus Profiles, which enables administrators to analyze physician performance metrics. Additionally, the company provides Kyruus MDSeekyr, a platform for identifying high-value providers, and Kyruus Insight Reports, which help executives evaluate network activity and performance trends. By leveraging a proprietary provider data management platform, Kyruus enhances patient engagement and aligns provider supply with patient demand, ultimately improving the overall healthcare experience. Kyruus also maintains offices in San Francisco and New York.
Kallyope
Series B in 2018
Kallyope Inc. is a biotechnology company based in New York City that focuses on the gut-brain axis to develop innovative therapeutics and consumer products aimed at enhancing human health. Founded in 2014, Kallyope employs a multidisciplinary approach, integrating technologies such as sequencing, computational biology, neural imaging, and human genetics to deepen the understanding of gut-brain biology. This comprehensive understanding enables the company to create effective and well-tolerated oral medications targeting various health issues, including diabetes, obesity, gut disorders, inflammatory diseases, migraines, and allergies. With a team of experienced scientists and a strong foundation in drug discovery, Kallyope aims to address significant unmet medical needs through its research and development efforts.
Pager
Series A in 2018
Pager, Inc. operates an on-demand service platform that connects patients with healthcare services in various settings, including their homes, offices, and hotels. The company offers a mobile application that addresses urgent care needs such as infections, fevers, and allergies, while also providing services like nurse chat, teleconsultations, screening, vaccinations, and prescription delivery. Pager aims to improve healthcare access and decision-making by employing a flexible platform that serves health plans and systems, enhancing consumer experience through information, guidance, and coordination. By integrating clinical and service teams with advanced technology, Pager facilitates triage, telemedicine, appointment scheduling, and health advocacy, fostering a comprehensive care experience. The company, incorporated in 2013 and based in New York, supports over 15 million covered lives in the United States and Latin America.
Citizen
Series A in 2017
Citizen is a mobile application that offers users real-time safety alerts and incident updates. It aims to enhance personal and community safety by notifying individuals about emergencies based on the latest 911 data. The app provides live stories, real-time updates, and user-generated content, allowing users to stay informed about local incidents and activities. Citizen has been recognized for its effectiveness in critical situations, such as evacuating people from dangerous environments and assisting in the reunification of missing persons with their families. With millions of downloads across the United States, the app operates in numerous urban markets, including New York City, San Francisco, Los Angeles, and Chicago, making it a vital tool for individuals seeking to ensure their safety and that of their loved ones.
Drone Racing League
Series B in 2017
Drone Racing League, Inc. is a New York-based organization that focuses on professional drone racing, catering to elite pilots. Founded in 2015, the company organizes tournaments and events that feature first-person perspective drone racing, where pilots navigate custom-designed and identical drones through intricate, thematic, three-dimensional racecourses. The league aims to create engaging 3D drone racing content that appeals to a wide audience, enhancing the spectator experience. In addition to hosting these competitions, the organization also sells tickets and provides media services related to drone racing events, contributing to the growing popularity of this unique sport.
Evolv Technology
Series B in 2017
Evolv Technology specializes in AI-based touchless security screening systems that prioritize safety while enhancing the visitor experience. The company's Mosaiq Platform integrates real-time video surveillance with advanced detection capabilities for firearms and explosives, facial recognition, and security analytics, all designed to minimize false alarms. Headquartered in Waltham, Massachusetts, Evolv is led by professionals with extensive backgrounds in security, including experience with the TSA, FBI, CIA, Secret Service, and Homeland Security. The firm offers its products through direct sales and a multi-year security-as-a-service subscription model, which not only provides ongoing value to clients but also fosters predictable revenue streams and opportunities for expansion. Evolv Technology aims to protect both public and private sectors by securing soft targets and vital assets.
Looking Glass
Series A in 2017
Looking Glass Factory is a company focused on developing holographic technology, primarily through its flagship product, the Looking Glass, which is the first desktop holographic display designed for 3D creators. Founded in 2015 and based in Brooklyn, New York, with a subsidiary in Hong Kong, the company aims to make 3D creation accessible without the need for virtual reality or augmented reality headsets. Looking Glass Factory also offers a web-based holographic sharing platform that utilizes light field rendering software, allowing artists, designers, developers, filmmakers, and photographers to engage with 3D content in an innovative manner.
Desktop Metal
Series C in 2017
Desktop Metal, Inc. specializes in additive manufacturing solutions, providing innovative 3D printing technologies tailored for engineers, designers, and manufacturers across various industries. Founded in 2015 and headquartered in Burlington, Massachusetts, the company offers a range of products, including the Production System for industrial manufacturing, the Shop System for metal additive manufacturing in machine and job shops, the Studio System for office-based metal 3D printing, and the Fiber desktop 3D printer. Its technologies cater to sectors such as automotive, aerospace, healthcare, consumer products, and heavy industry, enabling on-demand digital mass production that emphasizes speed, cost-efficiency, and high-quality parts. Desktop Metal operates in markets across the Americas, Europe, the Middle East, Africa, and the Asia-Pacific region, with the majority of its revenue generated from the Americas.
Alluvium
Seed Round in 2016
Alluvium, Inc. is a technology company based in Brooklyn, New York, that specializes in developing software tools and IoT solutions to enhance safety, productivity, and compliance in industrial operations. Founded in 2015, Alluvium connects factories with advanced geolocation technologies and AI, providing real-time operational insights that empower teams in foundational industries. Its core technology platform, known as the Stability Score, delivers critical information to management and plant leaders, enabling them to make informed decisions that improve workplace safety and efficiency. Alluvium's commitment to reliable hardware and software ensures uninterrupted service, helping businesses to digitize their safety and productivity measures and remain competitive in the global economy. As of early 2019, Alluvium operates as a subsidiary of Augury Inc.
Clarifai
Series B in 2016
Clarifai, Inc. is a prominent provider of advanced artificial intelligence solutions specializing in image recognition, natural language processing, and audio recognition. Founded in 2013 by Matt Zeiler, Ph.D., the company develops a deep learning platform that enables organizations to convert unstructured data—such as images, videos, text, and audio—into structured data efficiently and accurately. Clarifai's image recognition technology is capable of detecting near-duplicates, categorizing objects, and tagging images, while also allowing users to search for similar images within extensive uncategorized collections through a combination of semantic and visual similarity. Additionally, the company offers a labeling tool called Labeler, which aids in dataset labeling, AI training, and model auto-scaling in production environments. Headquartered in New York, with an office in Tallinn, Estonia, Clarifai employs a distributed team across various countries, including the United States, Canada, Argentina, and India.
Workit Health
Seed Round in 2016
Workit Health, Inc. is a provider of online therapeutic content and professional counseling services focused on substance use recovery. Established in 2014 and based in Ann Arbor, Michigan, the company operates the Workit platform, which offers clinically proven telemedicine treatment for substance use disorder, including online therapy, medication-assisted treatment, psychiatric support, and primary care. Workit Health's services are designed to help individuals achieve long-term recovery from drugs and alcohol while minimizing disruption to their daily lives. The platform facilitates access to on-demand, in-person, and virtual medical and psychosocial support, catering to a wide range of clients including employers, educational institutions, healthcare facilities, and recovery communities. Additionally, Workit Health provides accredited opioid addiction treatment featuring buprenorphine, enhancing its commitment to harm reduction in addiction care. The company has locations in California, New Jersey, Alaska, and Washington.
Desktop Metal
Series B in 2016
Desktop Metal, Inc. specializes in additive manufacturing solutions, providing innovative 3D printing technologies tailored for engineers, designers, and manufacturers across various industries. Founded in 2015 and headquartered in Burlington, Massachusetts, the company offers a range of products, including the Production System for industrial manufacturing, the Shop System for metal additive manufacturing in machine and job shops, the Studio System for office-based metal 3D printing, and the Fiber desktop 3D printer. Its technologies cater to sectors such as automotive, aerospace, healthcare, consumer products, and heavy industry, enabling on-demand digital mass production that emphasizes speed, cost-efficiency, and high-quality parts. Desktop Metal operates in markets across the Americas, Europe, the Middle East, Africa, and the Asia-Pacific region, with the majority of its revenue generated from the Americas.
Kala Pharmaceuticals
Series C in 2016
Kala Pharmaceuticals, Inc. is a biopharmaceutical company headquartered in Watertown, Massachusetts, that specializes in developing therapies for diseases affecting mucosal tissues using its proprietary nanoparticle-based Mucus Penetrating Particles (MPP) technology. This innovative approach enhances drug distribution and pharmacokinetics by delivering biocompatible, drug-loaded particles that uniformly coat mucosal surfaces. The company's lead product candidate, KPI-121 0.25%, has successfully completed two Phase III clinical trials aimed at providing temporary relief for dry eye disease. Additionally, INVELTYS, another product, has also completed two Phase III trials for treating inflammation and pain following ocular surgery. Kala is advancing its pipeline, including KPI-285, a receptor tyrosine kinase inhibitor for retinal diseases, which is currently in preclinical studies. The company aims to address significant clinical needs while exploring research collaborations to enhance its product offerings.
Kallyope
Series A in 2015
Kallyope Inc. is a biotechnology company based in New York City that focuses on the gut-brain axis to develop innovative therapeutics and consumer products aimed at enhancing human health. Founded in 2014, Kallyope employs a multidisciplinary approach, integrating technologies such as sequencing, computational biology, neural imaging, and human genetics to deepen the understanding of gut-brain biology. This comprehensive understanding enables the company to create effective and well-tolerated oral medications targeting various health issues, including diabetes, obesity, gut disorders, inflammatory diseases, migraines, and allergies. With a team of experienced scientists and a strong foundation in drug discovery, Kallyope aims to address significant unmet medical needs through its research and development efforts.
Zipdrug
Seed Round in 2015
Zipdrug, Inc. is a New York-based company that develops a mobile application designed to streamline the process of obtaining prescribed medications. Founded in 2015, the application connects users with a network of low-cost pharmacies that deliver prescriptions directly to patients' homes, eliminating the need to wait at traditional pharmacies. By focusing on Medicare and Medicaid patients, Zipdrug aims to enhance medication adherence while providing a personalized pharmacy experience at competitive prices. As of July 2020, Zipdrug operates as a subsidiary of IngenioRx, Inc.
Looking Glass
Seed Round in 2015
Looking Glass Factory is a company focused on developing holographic technology, primarily through its flagship product, the Looking Glass, which is the first desktop holographic display designed for 3D creators. Founded in 2015 and based in Brooklyn, New York, with a subsidiary in Hong Kong, the company aims to make 3D creation accessible without the need for virtual reality or augmented reality headsets. Looking Glass Factory also offers a web-based holographic sharing platform that utilizes light field rendering software, allowing artists, designers, developers, filmmakers, and photographers to engage with 3D content in an innovative manner.
Desktop Metal
Series A in 2015
Desktop Metal, Inc. specializes in additive manufacturing solutions, providing innovative 3D printing technologies tailored for engineers, designers, and manufacturers across various industries. Founded in 2015 and headquartered in Burlington, Massachusetts, the company offers a range of products, including the Production System for industrial manufacturing, the Shop System for metal additive manufacturing in machine and job shops, the Studio System for office-based metal 3D printing, and the Fiber desktop 3D printer. Its technologies cater to sectors such as automotive, aerospace, healthcare, consumer products, and heavy industry, enabling on-demand digital mass production that emphasizes speed, cost-efficiency, and high-quality parts. Desktop Metal operates in markets across the Americas, Europe, the Middle East, Africa, and the Asia-Pacific region, with the majority of its revenue generated from the Americas.
Kyruus
Series C in 2015
Kyruus, Inc. is a Boston-based company that develops web-based software solutions aimed at optimizing physician networks for hospitals, health systems, and life science companies. Founded in 2010, Kyruus offers a suite of analytically driven products designed to enhance provider search and scheduling, ensuring that patients are matched with the most suitable healthcare providers. Key offerings include Kyruus Passport, which allows physicians to track their activity and productivity, and Kyruus Profiles, which enables administrators to analyze physician performance metrics. Additionally, the company provides Kyruus MDSeekyr, a platform for identifying high-value providers, and Kyruus Insight Reports, which help executives evaluate network activity and performance trends. By leveraging a proprietary provider data management platform, Kyruus enhances patient engagement and aligns provider supply with patient demand, ultimately improving the overall healthcare experience. Kyruus also maintains offices in San Francisco and New York.
Pager
Series A in 2015
Pager, Inc. operates an on-demand service platform that connects patients with healthcare services in various settings, including their homes, offices, and hotels. The company offers a mobile application that addresses urgent care needs such as infections, fevers, and allergies, while also providing services like nurse chat, teleconsultations, screening, vaccinations, and prescription delivery. Pager aims to improve healthcare access and decision-making by employing a flexible platform that serves health plans and systems, enhancing consumer experience through information, guidance, and coordination. By integrating clinical and service teams with advanced technology, Pager facilitates triage, telemedicine, appointment scheduling, and health advocacy, fostering a comprehensive care experience. The company, incorporated in 2013 and based in New York, supports over 15 million covered lives in the United States and Latin America.
Clarifai
Series A in 2015
Clarifai, Inc. is a prominent provider of advanced artificial intelligence solutions specializing in image recognition, natural language processing, and audio recognition. Founded in 2013 by Matt Zeiler, Ph.D., the company develops a deep learning platform that enables organizations to convert unstructured data—such as images, videos, text, and audio—into structured data efficiently and accurately. Clarifai's image recognition technology is capable of detecting near-duplicates, categorizing objects, and tagging images, while also allowing users to search for similar images within extensive uncategorized collections through a combination of semantic and visual similarity. Additionally, the company offers a labeling tool called Labeler, which aids in dataset labeling, AI training, and model auto-scaling in production environments. Headquartered in New York, with an office in Tallinn, Estonia, Clarifai employs a distributed team across various countries, including the United States, Canada, Argentina, and India.
Pager
Venture Round in 2015
Pager, Inc. operates an on-demand service platform that connects patients with healthcare services in various settings, including their homes, offices, and hotels. The company offers a mobile application that addresses urgent care needs such as infections, fevers, and allergies, while also providing services like nurse chat, teleconsultations, screening, vaccinations, and prescription delivery. Pager aims to improve healthcare access and decision-making by employing a flexible platform that serves health plans and systems, enhancing consumer experience through information, guidance, and coordination. By integrating clinical and service teams with advanced technology, Pager facilitates triage, telemedicine, appointment scheduling, and health advocacy, fostering a comprehensive care experience. The company, incorporated in 2013 and based in New York, supports over 15 million covered lives in the United States and Latin America.
Sols
Series B in 2015
SOLS is a software platform and mobile application that enables users to design and purchase customized orthotics for their feet. To date, the company has launched two products: SOLSRx, medical-grade 3D printed orthotics, and ExoSOLS, direct to consumer custom insoles. SOLS is now leveraging its patented footwear customization software to attack the footwear industry's biggest problem, shoe size-related returns. Founded in 2013, SOLS uses state of the art computer vision and machine learning to improve the fit and function of footwear. The company is backed by blue-chip investors like Founders Fund, Lux Capital, and Tenaya Capital and located in New York City.
Toonimo
Venture Round in 2014
Toonimo Inc. is a New York-based company that specializes in developing plug-in software designed to enhance user experience on websites through interactive audio-visual guidance. Founded in 2013, Toonimo provides a Digital Adoption Platform that assists enterprises in streamlining employee training and customer onboarding processes. Its solutions integrate real-time learning tools directly into software applications, allowing users to learn by doing rather than through traditional eLearning modules or manuals. This approach utilizes text bubbles, audio, and visual cues to create an engaging self-service environment, significantly improving user adoption rates and enhancing task efficiency. Toonimo serves various industries, including finance, healthcare, telecommunications, education, and travel, by offering tailored guidance solutions for platforms such as Salesforce, Microsoft Dynamics, and Oracle CRM.
Pager
Venture Round in 2014
Pager, Inc. operates an on-demand service platform that connects patients with healthcare services in various settings, including their homes, offices, and hotels. The company offers a mobile application that addresses urgent care needs such as infections, fevers, and allergies, while also providing services like nurse chat, teleconsultations, screening, vaccinations, and prescription delivery. Pager aims to improve healthcare access and decision-making by employing a flexible platform that serves health plans and systems, enhancing consumer experience through information, guidance, and coordination. By integrating clinical and service teams with advanced technology, Pager facilitates triage, telemedicine, appointment scheduling, and health advocacy, fostering a comprehensive care experience. The company, incorporated in 2013 and based in New York, supports over 15 million covered lives in the United States and Latin America.
Sols
Series A in 2014
SOLS is a software platform and mobile application that enables users to design and purchase customized orthotics for their feet. To date, the company has launched two products: SOLSRx, medical-grade 3D printed orthotics, and ExoSOLS, direct to consumer custom insoles. SOLS is now leveraging its patented footwear customization software to attack the footwear industry's biggest problem, shoe size-related returns. Founded in 2013, SOLS uses state of the art computer vision and machine learning to improve the fit and function of footwear. The company is backed by blue-chip investors like Founders Fund, Lux Capital, and Tenaya Capital and located in New York City.
Kala Pharmaceuticals
Series B in 2014
Kala Pharmaceuticals, Inc. is a biopharmaceutical company headquartered in Watertown, Massachusetts, that specializes in developing therapies for diseases affecting mucosal tissues using its proprietary nanoparticle-based Mucus Penetrating Particles (MPP) technology. This innovative approach enhances drug distribution and pharmacokinetics by delivering biocompatible, drug-loaded particles that uniformly coat mucosal surfaces. The company's lead product candidate, KPI-121 0.25%, has successfully completed two Phase III clinical trials aimed at providing temporary relief for dry eye disease. Additionally, INVELTYS, another product, has also completed two Phase III trials for treating inflammation and pain following ocular surgery. Kala is advancing its pipeline, including KPI-285, a receptor tyrosine kinase inhibitor for retinal diseases, which is currently in preclinical studies. The company aims to address significant clinical needs while exploring research collaborations to enhance its product offerings.
Sols
Seed Round in 2013
SOLS is a software platform and mobile application that enables users to design and purchase customized orthotics for their feet. To date, the company has launched two products: SOLSRx, medical-grade 3D printed orthotics, and ExoSOLS, direct to consumer custom insoles. SOLS is now leveraging its patented footwear customization software to attack the footwear industry's biggest problem, shoe size-related returns. Founded in 2013, SOLS uses state of the art computer vision and machine learning to improve the fit and function of footwear. The company is backed by blue-chip investors like Founders Fund, Lux Capital, and Tenaya Capital and located in New York City.
Visterra
Series A in 2013
Visterra, Inc. engages in pharmaceutical drug research and development of therapeutic and diagnostic products for infectious diseases. It also provides structure-based design of therapeutics and diagnostic platforms, based on an understanding of glycobiology and glycochemistry. The company was formerly known as Parasol Therapeutics, Inc. and changed its name in May 2010. Visterra, Inc. was founded in 2007 and is based in Cambridge, Massachusetts.
Evolv Technology
Series A in 2013
Evolv Technology specializes in AI-based touchless security screening systems that prioritize safety while enhancing the visitor experience. The company's Mosaiq Platform integrates real-time video surveillance with advanced detection capabilities for firearms and explosives, facial recognition, and security analytics, all designed to minimize false alarms. Headquartered in Waltham, Massachusetts, Evolv is led by professionals with extensive backgrounds in security, including experience with the TSA, FBI, CIA, Secret Service, and Homeland Security. The firm offers its products through direct sales and a multi-year security-as-a-service subscription model, which not only provides ongoing value to clients but also fosters predictable revenue streams and opportunities for expansion. Evolv Technology aims to protect both public and private sectors by securing soft targets and vital assets.
Shapeways
Series C in 2013
Shapeways, Inc. is a 3D printing marketplace and community that allows users to create, buy, and sell customized products across various categories, including art, fashion, home goods, gadgets, games, jewelry, DIY projects, miniatures, and gifts. Founded in 2008 and headquartered in New York, with additional offices in Eindhoven, Netherlands, and Seattle, Washington, Shapeways utilizes on-demand printing to ensure that each order is tailored to individual specifications. The platform not only facilitates the transformation of digital designs into physical products but also fosters a community where members can share ideas and access advanced 3D printing technology. By democratizing the creation process, Shapeways empowers users to launch their own businesses and sell products globally.
Kyruus
Series B in 2013
Kyruus, Inc. is a Boston-based company that develops web-based software solutions aimed at optimizing physician networks for hospitals, health systems, and life science companies. Founded in 2010, Kyruus offers a suite of analytically driven products designed to enhance provider search and scheduling, ensuring that patients are matched with the most suitable healthcare providers. Key offerings include Kyruus Passport, which allows physicians to track their activity and productivity, and Kyruus Profiles, which enables administrators to analyze physician performance metrics. Additionally, the company provides Kyruus MDSeekyr, a platform for identifying high-value providers, and Kyruus Insight Reports, which help executives evaluate network activity and performance trends. By leveraging a proprietary provider data management platform, Kyruus enhances patient engagement and aligns provider supply with patient demand, ultimately improving the overall healthcare experience. Kyruus also maintains offices in San Francisco and New York.
Visterra
Series A in 2012
Visterra, Inc. engages in pharmaceutical drug research and development of therapeutic and diagnostic products for infectious diseases. It also provides structure-based design of therapeutics and diagnostic platforms, based on an understanding of glycobiology and glycochemistry. The company was formerly known as Parasol Therapeutics, Inc. and changed its name in May 2010. Visterra, Inc. was founded in 2007 and is based in Cambridge, Massachusetts.
Genocea Biosciences
Series C in 2012
Genocea Biosciences is a biopharmaceutical company based in Cambridge, Massachusetts, focused on the discovery and development of innovative cancer immunotherapies and vaccines. Utilizing its proprietary ATLAS platform, the company profiles patients' CD4+ and CD8+ T cell immune responses to identify potential antigens in tumors. Genocea is advancing several immuno-oncology programs, including GEN-009, an adjuvanted neoantigen peptide vaccine currently in phase I/IIa clinical trials, and GEN-011, a neoantigen adoptive T cell therapy. Additionally, the company has developed GEN-003, an immunotherapy aimed at treating genital herpes, and is working on personalized cancer vaccines through its pre-clinical immuno-oncology program. Established in 2006, Genocea aims to address significant unmet medical needs with its targeted therapeutic approaches.
Shapeways
Series B in 2012
Shapeways, Inc. is a 3D printing marketplace and community that allows users to create, buy, and sell customized products across various categories, including art, fashion, home goods, gadgets, games, jewelry, DIY projects, miniatures, and gifts. Founded in 2008 and headquartered in New York, with additional offices in Eindhoven, Netherlands, and Seattle, Washington, Shapeways utilizes on-demand printing to ensure that each order is tailored to individual specifications. The platform not only facilitates the transformation of digital designs into physical products but also fosters a community where members can share ideas and access advanced 3D printing technology. By democratizing the creation process, Shapeways empowers users to launch their own businesses and sell products globally.
Kala Pharmaceuticals
Private Equity Round in 2012
Kala Pharmaceuticals, Inc. is a biopharmaceutical company headquartered in Watertown, Massachusetts, that specializes in developing therapies for diseases affecting mucosal tissues using its proprietary nanoparticle-based Mucus Penetrating Particles (MPP) technology. This innovative approach enhances drug distribution and pharmacokinetics by delivering biocompatible, drug-loaded particles that uniformly coat mucosal surfaces. The company's lead product candidate, KPI-121 0.25%, has successfully completed two Phase III clinical trials aimed at providing temporary relief for dry eye disease. Additionally, INVELTYS, another product, has also completed two Phase III trials for treating inflammation and pain following ocular surgery. Kala is advancing its pipeline, including KPI-285, a receptor tyrosine kinase inhibitor for retinal diseases, which is currently in preclinical studies. The company aims to address significant clinical needs while exploring research collaborations to enhance its product offerings.
Madaket
Seed Round in 2012
Madaket, Inc. is a provider of SaaS solutions focused on the healthcare industry, headquartered in Cambridge, Massachusetts. Founded in 2012, the company specializes in automating healthcare enrollment processes, effectively connecting healthcare providers and payers to streamline administrative tasks. Madaket's platform enhances efficiency by reducing manual errors and allowing organizations to track the status of enrollments. The company has established exclusive partnerships with TriZetto Provider Solutions and HealthStream, facilitating access to a network that includes over 300,000 providers already in its system and an additional 325,000 providers under contract.
Genocea Biosciences
Series B in 2011
Genocea Biosciences is a biopharmaceutical company based in Cambridge, Massachusetts, focused on the discovery and development of innovative cancer immunotherapies and vaccines. Utilizing its proprietary ATLAS platform, the company profiles patients' CD4+ and CD8+ T cell immune responses to identify potential antigens in tumors. Genocea is advancing several immuno-oncology programs, including GEN-009, an adjuvanted neoantigen peptide vaccine currently in phase I/IIa clinical trials, and GEN-011, a neoantigen adoptive T cell therapy. Additionally, the company has developed GEN-003, an immunotherapy aimed at treating genital herpes, and is working on personalized cancer vaccines through its pre-clinical immuno-oncology program. Established in 2006, Genocea aims to address significant unmet medical needs with its targeted therapeutic approaches.
Visterra
Debt Financing in 2010
Visterra, Inc. engages in pharmaceutical drug research and development of therapeutic and diagnostic products for infectious diseases. It also provides structure-based design of therapeutics and diagnostic platforms, based on an understanding of glycobiology and glycochemistry. The company was formerly known as Parasol Therapeutics, Inc. and changed its name in May 2010. Visterra, Inc. was founded in 2007 and is based in Cambridge, Massachusetts.
Genocea Biosciences
Series B in 2009
Genocea Biosciences is a biopharmaceutical company based in Cambridge, Massachusetts, focused on the discovery and development of innovative cancer immunotherapies and vaccines. Utilizing its proprietary ATLAS platform, the company profiles patients' CD4+ and CD8+ T cell immune responses to identify potential antigens in tumors. Genocea is advancing several immuno-oncology programs, including GEN-009, an adjuvanted neoantigen peptide vaccine currently in phase I/IIa clinical trials, and GEN-011, a neoantigen adoptive T cell therapy. Additionally, the company has developed GEN-003, an immunotherapy aimed at treating genital herpes, and is working on personalized cancer vaccines through its pre-clinical immuno-oncology program. Established in 2006, Genocea aims to address significant unmet medical needs with its targeted therapeutic approaches.
Visterra
Seed Round in 2009
Visterra, Inc. engages in pharmaceutical drug research and development of therapeutic and diagnostic products for infectious diseases. It also provides structure-based design of therapeutics and diagnostic platforms, based on an understanding of glycobiology and glycochemistry. The company was formerly known as Parasol Therapeutics, Inc. and changed its name in May 2010. Visterra, Inc. was founded in 2007 and is based in Cambridge, Massachusetts.
Genocea Biosciences
Series A in 2009
Genocea Biosciences is a biopharmaceutical company based in Cambridge, Massachusetts, focused on the discovery and development of innovative cancer immunotherapies and vaccines. Utilizing its proprietary ATLAS platform, the company profiles patients' CD4+ and CD8+ T cell immune responses to identify potential antigens in tumors. Genocea is advancing several immuno-oncology programs, including GEN-009, an adjuvanted neoantigen peptide vaccine currently in phase I/IIa clinical trials, and GEN-011, a neoantigen adoptive T cell therapy. Additionally, the company has developed GEN-003, an immunotherapy aimed at treating genital herpes, and is working on personalized cancer vaccines through its pre-clinical immuno-oncology program. Established in 2006, Genocea aims to address significant unmet medical needs with its targeted therapeutic approaches.
Magen BioSciences
Series A in 2006
Magen BioSciences is a biotechnology company based in Waltham, Massachusetts, focused on developing pharmaceutical products aimed at enhancing human skin health. Utilizing a science-driven approach, the company leverages its comprehensive understanding of both normal and diseased skin biology to create solutions that improve the health and appearance of the skin.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.